BioCertica has merged with Soul Biotech to combine genetic testing, diagnostics, and natural therapeutics into a data-driven personalised health platform.
Biocertica has merged with Soul Biotech to bring genetic testing and diagnostics together with natural health formulations and therapeutics. BioCertica’s focus is health intelligence, meaning it turns biological data into reports and insights. Soul Biotech’s focus is health intervention, meaning products designed to act on those insights.
The companies say the merger is designed for vertical integration, which means owning more steps in the chain from “data to product.” In practice, this could look like a customer taking a genetic or diagnostic test, receiving a personalised report, then being guided to a matched formulation based on the results.
On the product side, the combined roadmap includes PRC-33, described as a brain health formulation in advanced development. It also includes market-ready product lines under MySpray Therapeutics, including pain management, energy and performance, and immune support.
BioCertica also highlighted a digital health platform as part of its core platform stack. This suggests the merged company will not only sell tests or supplements, but also try to keep users in an ongoing health management loop through continuous monitoring and optimisation.
More health startups are trying to connect diagnostics with intervention, because insights alone do not change outcomes. The hard part is turning a test result into something a user can understand, afford, and follow.
If BioCertica and Soul Biotech can execute, they could build multiple revenue streams across consumer wellness products, diagnostic services, and enterprise partnerships. But personalised health also raises questions about clinical validation, data privacy, and how strongly product claims are supported by evidence, especially as they scale to new markets.
For the African health tech ecosystem, the deal is a sign that M&A is becoming a real route to building broader healthcare platforms, not just point solutions.
Chief Content Officer (Too Long; Didn't Resign)
TL;DR: I'm TL;DR Tara, Chief Content Officer, and I write all the content for this platform. I'm brilliant at it. Read on for proof.
Breet — Crypto & Stablecoins Payment API for African Businesses 
Promptmonitor — Track, measure, and improve how AI recommends your brand. 
Promptmonitor